CDNA
Caredx Inc

3,255
Mkt Cap
$919.1M
Volume
245,496.00
52W High
$26.37
52W Low
$10.96
PE Ratio
14.99
CDNA Fundamentals
Price
$17.87
Prev Close
$17.81
Open
$18.01
50D MA
$15.37
Beta
1.51
Avg. Volume
1.02M
EPS (Annual)
$0.9281
P/B
2.95
Rev/Employee
$513,515.39
Loading...
Loading...
News
all
press releases
Wall Street Analysts Believe CareDx (CDNA) Could Rally 28.02%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 28% in CareDx (CDNA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks·2d ago
News Placeholder
More News
News Placeholder
CareDx, Inc. (NASDAQ:CDNA) Given Consensus Rating of "Hold" by Brokerages
CareDx, Inc. (NASDAQ:CDNA - Get Free Report) has been given a consensus recommendation of "Hold" by the nine research firms that are presently covering the stock, MarketBeat reports. Five investment...
MarketBeat·2d ago
News Placeholder
CareDx (NASDAQ:CDNA) Raised to Hold at Zacks Research
Zacks Research upgraded shares of CareDx from a "strong sell" rating to a "hold" rating in a research report on Tuesday...
MarketBeat·8d ago
News Placeholder
SG Capital Management LLC Takes Position in CareDx, Inc. $CDNA
SG Capital Management LLC bought a new stake in shares of CareDx, Inc. (NASDAQ:CDNA - Free Report) during the second quarter, according to the company in its most recent 13F filing with the...
MarketBeat·13d ago
News Placeholder
Acadian Asset Management LLC Sells 243,776 Shares of CareDx, Inc. $CDNA
Acadian Asset Management LLC reduced its position in CareDx, Inc. (NASDAQ:CDNA - Free Report) by 67.8% during the second quarter, according to the company in its most recent filing with the...
MarketBeat·13d ago
News Placeholder
CareDx to Participate in Upcoming Investor Conferences
CareDx, Inc. (Nasdaq: CDNA)- The Transplant Company a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value...
Business Wire·19d ago
News Placeholder
Y Intercept Hong Kong Ltd Buys Shares of 19,474 CareDx, Inc. $CDNA
Y Intercept Hong Kong Ltd purchased a new position in CareDx, Inc. (NASDAQ:CDNA - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange...
MarketBeat·20d ago
News Placeholder
CareDx (NASDAQ:CDNA) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen upgraded shares of CareDx from a "sell" rating to a "buy" rating in a research note on Saturday...
MarketBeat·21d ago
News Placeholder
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CareDx, Inc. (Nasdaq: CDNA) The Transplant Company a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value...
Business Wire·22d ago
News Placeholder
CareDx (NASDAQ:CDNA) Given New $25.00 Price Target at BTIG Research
BTIG Research raised their price objective on CareDx from $22.00 to $25.00 and gave the stock a "buy" rating in a research note on Thursday...
MarketBeat·22d ago

Latest CDNA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.